GammaDelta Therapeutics

Description: GammaDelta Therapeutics develops allogeneic immunotherapies using γδ T cells to treat cancers, improving patient survival rates.

Country: UK

Based in: London

Founded: 2016

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Health Diagnostics', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.